Table 2.
Descriptive characteristics of 62 metastatic renal medullary and 186 clear cell RCC in the SEER database 2000–2021 stratified according to receipt of cytoreductive nephrectomy
| Characteristic | Medullary RCC n = 62 (25%) |
Clear cell RCC n = 186 (75%) |
||||
|---|---|---|---|---|---|---|
| Cytoreductive nephrectomy n = 30 (48%)1 |
No cytoreductive nephrectomy n = 32 (52%)1 |
p-value | Cytoreductive nephrectomy n = 97 (52%)1 |
No cytoreductive nephrectomy n = 89 (48%)1 |
p-value | |
| Age | 30 (20, 56) | 24 (18, 39) | 0.01 | 53 (48, 56) | 53 (47, 57) | 0.9 |
| Male sex | 24 (80%) | 21 (66%) | 0.2 | 67 (69%) | 62 (70%) | 0.9 |
| T Stage | 0.3 | 0.10 | ||||
| T1-2 | 6 (20%) | 10 (31%) | 30 (31%) | 18 (20%) | ||
| T3-4 | 24 (80%) | 22 (69%) | 67 (69%) | 71 (80%) | ||
| N Stage | 0.8 | 1.0 | ||||
| N0/Nx | 14 (47%) | 16 (50%) | 47 (48%) | 43 (48%) | ||
| N1 | 16 (53%) | 16 (50%) | 50 (52%) | 46 (52%) | ||
| Race | 0.2 | 0.4 | ||||
| Caucasian | 3 (10%) | 0 (0%) | 5 (5%) | 4 (5%) | ||
| African Americans | 22 (73%) | 24 (75%) | 68 (70%) | 70 (79%) | ||
| Other | 5 (17%) | 8 (25%) | 24 (25%) | 15 (17%) | ||
1Median (Q1, Q3);n(%)